Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 31, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Rapid HATU-mediated solution phase siRNA conjugation.

Jeffrey G Aaronson¹, Lee J Klein, Aaron A Momose

¹Department of Medicinal Chemistry, Merck Research Laboratories, Merck & Co., Inc., West Point, Pennsylvania 19486, United States. jeffrey_aaronson@merck.com

Bioconjugate Chemistry

|July 13, 2011

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR.

Journal of medicinal chemistry·2026

Same author

Integrated <i>In Silico</i>, <i>Ex Vivo</i>, and <i>In Vitro</i> Framework for Early Derisking of Mast Cell Degranulation in Peptide Drug Candidates.

Chemical research in toxicology·2025

Same author

Rational design and relative bioperformance of high drug load grazoprevir amorphous nanoparticle formulations.

Pharmaceutical development and technology·2025

Same author

Why do microplastics aggravate cholestatic liver disease? The NLRP3-mediated intestinal barrier integrity damage matter.

Environmental pollution (Barking, Essex : 1987)·2025

Same author

Clinical evaluation of droplet digital PCR in suspected invasive pulmonary aspergillosis.

Clinica chimica acta; international journal of clinical chemistry·2025

Same author

Enhanced Spontaneous Emission Rate and Luminescence Intensity of CsPbBr<sub>3</sub> Quantum Dots Using a High-<i>Q</i> Microdisk Cavity.

The journal of physical chemistry letters·2025

This study details a simple method for creating modified siRNA molecules by linking them with various carboxylic acids using HATU. This approach allows for quick production of functionalized siRNA with tunable properties.

Area of Science:

Bioconjugation Chemistry
Oligonucleotide Therapeutics

Background:

siRNA (small interfering RNA) is a key tool in gene silencing.
Developing efficient methods for modifying siRNA is crucial for enhancing its therapeutic applications.
Current conjugation methods can be complex and require multiple steps.

Purpose of the Study:

To describe facile conditions for amide conjugation of amine-modified siRNA.
To enable rapid synthesis of siRNA conjugates with diverse properties.
To avoid the need for intermediate activated esters.

Main Methods:

Utilized the coupling reagent HATU for direct amide bond formation.
Conjugated amine-modified siRNA with a variety of carboxylic acid partners.
Performed reactions in solution phase.

More Related Videos

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

Related Experiment Videos

Last Updated: May 31, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

Main Results:

Achieved facile solution-phase amide conjugation of siRNA.
Demonstrated successful conjugation with a diverse range of carboxylic acid partners.
Obtained conjugates with a wide range of lipophilicity and functionality in good yield.

Conclusions:

The described HATU-mediated conditions provide a straightforward and efficient route to functionalized siRNA.
This method simplifies the synthesis of siRNA conjugates, broadening their potential therapeutic utility.
The ability to tune lipophilicity and functionality is advantageous for drug delivery applications.